Evommune, Inc. (EVMN)

NYSE: EVMN · Real-Time Price · USD

12.66

-0.57 (-4.31%)

At close: Aug 31, 2026, 4:00 PM EDT

12.60

-0.06 (-0.47%)

After-hours: Aug 31, 2026, 7:36 PM EDT

Evommune Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-94.67	-68.87	-66.81	-34.05
Depreciation & Amortization	1.54	1.39	1.29	1
Loss (Gain) From Sale of Investments	-2.64	-1.77	-1.82	-1.75
Stock-Based Compensation	12.81	5.86	1.72	1.48
Other Operating Activities	-	-8.93	-	-
Change in Accounts Payable	0.99	-0.84	6.51	0.13
Change in Unearned Revenue	-	-3	-	3
Change in Other Net Operating Assets	7.83	-0.28	0.92	0.22
Operating Cash Flow	-74.15	-76.44	-58.2	-29.97
Operating Cash Flow Growth	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Capital Expenditures	-0.5	-0.24	-0.09	-0.12
Investment in Securities	-200.37	-115.07	-3.91	-48.32
Investing Cash Flow	-200.87	-115.31	-3.99	-48.43

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Long-Term Debt Repaid	-	-0.53	-0.42	-0.23
Net Debt Issued (Repaid)	-0.45	-0.53	-0.42	-0.23
Issuance of Common Stock	275.16	157.29	0.01	0.01
Repurchase of Common Stock	-1.22	-1.22	-	-
Financing Cash Flow	274.22	220.76	49.42	63.75

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Cash Flow	-0.81	29.02	-12.77	-14.65

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-74.65	-76.68	-58.28	-30.09
Free Cash Flow Growth	-	-	-	-
Free Cash Flow Margin	-746.54%	-589.82%	-832.61%	-601.76%
Free Cash Flow Per Share	-3.27	-12.49	-38.64	-24.01
Levered Free Cash Flow	-39.13	-56.17	-20.45	-
Unlevered Free Cash Flow	-39.13	-56.16	-20.43	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash Interest Paid	0	0.01	0.03	0.06
Change in Working Capital	8.81	-4.12	7.42	3.34

SEC Filings: 10-K · 10-Q